These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2398 related items for PubMed ID: 22244725

  • 21. [Outcomes of AL-amyloidosis treatment with bortezomib, dexamethasone and cyclophosphamide or doxorubicin-containing regimens].
    Adam Z, Stork M, Pour L, Krejčí M, Zahradová L, Sandecká V, Hájek R, Cermáková Z, Pospíšilová Y, Navrátil M, Král Z, Mayer J.
    Vnitr Lek; 2012 Dec; 58(12):896-903. PubMed ID: 23427947
    [Abstract] [Full Text] [Related]

  • 22. Spectrum of glomerular and tubulointerstitial renal lesions associated with monotypical immunoglobulin light chain deposition.
    Sanders PW, Herrera GA, Kirk KA, Old CW, Galla JH.
    Lab Invest; 1991 Apr; 64(4):527-37. PubMed ID: 1901926
    [Abstract] [Full Text] [Related]

  • 23. Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study.
    Joly F, Cohen C, Javaugue V, Bender S, Belmouaz M, Arnulf B, Knebelmann B, Nouvier M, Audard V, Provot F, Gnemmi V, Nochy D, Goujon JM, Jaccard A, Touchard G, Fermand JP, Sirac C, Bridoux F.
    Blood; 2019 Feb 07; 133(6):576-587. PubMed ID: 30578255
    [Abstract] [Full Text] [Related]

  • 24. [Randall-type monoclonal immunoglobulin deposition disease: From diagnosis to treatment].
    Cohen C, Javaugue V, Joly F, Arnulf B, Fermand JP, Jaccard A, Sirac C, Knebelmann B, Bridoux F, Touchard G.
    Nephrol Ther; 2016 Jun 07; 12(3):131-9. PubMed ID: 27117766
    [Abstract] [Full Text] [Related]

  • 25. [Multiple myeloma and renal impairment].
    Takahashi N.
    Nihon Rinsho; 2015 Jan 07; 73(1):38-41. PubMed ID: 25626301
    [Abstract] [Full Text] [Related]

  • 26. Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies.
    Montseny JJ, Kleinknecht D, Meyrier A, Vanhille P, Simon P, Pruna A, Eladari D.
    Nephrol Dial Transplant; 1998 Jun 07; 13(6):1438-45. PubMed ID: 9641173
    [Abstract] [Full Text] [Related]

  • 27. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
    Picken MM.
    Contrib Nephrol; 2007 Jun 07; 153():135-55. PubMed ID: 17075228
    [Abstract] [Full Text] [Related]

  • 28. [Renal disease in multiple myeloma].
    Hiromura K, Nojima Y.
    Nihon Rinsho; 2007 Dec 07; 65(12):2229-34. PubMed ID: 18069265
    [Abstract] [Full Text] [Related]

  • 29. Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosis.
    Comenzo RL.
    Contrib Nephrol; 2007 Dec 07; 153():195-210. PubMed ID: 17075231
    [Abstract] [Full Text] [Related]

  • 30. Bortezomib successfully reverses early recurrence of light-chain deposition disease in a renal allograft: a case report.
    Kaposztas Z, Kahan BD, Katz SM, Van Buren CT, Cherem L.
    Transplant Proc; 2009 Dec 07; 41(10):4407-10. PubMed ID: 20005409
    [Abstract] [Full Text] [Related]

  • 31. Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light- and heavy-chain deposition diseases.
    Buxbaum J, Gallo G.
    Hematol Oncol Clin North Am; 1999 Dec 07; 13(6):1235-48. PubMed ID: 10626147
    [Abstract] [Full Text] [Related]

  • 32. [Treatment of AL-amyloidosis--results from one clinic and review of published experience with new agents (bortezomib, thalidomide and lenalidomide) in AL-amyloidosis].
    Adam Z, Pour L, Krejcí M, Zahradová L, Krivanová A, Mardová J, Kovárová L, Stepánková S, Moulis M, Kren L, Veselý K, Svobodová I, Germáková Z, Nedbálková M, Mayer J, Hájek R.
    Vnitr Lek; 2010 Mar 07; 56(3):190-209. PubMed ID: 20394205
    [Abstract] [Full Text] [Related]

  • 33. Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory.
    Herrera GA.
    Ann Diagn Pathol; 2000 Jun 07; 4(3):174-200. PubMed ID: 10919389
    [Abstract] [Full Text] [Related]

  • 34. [Improved prognosis in light chain nephropathy due to multiple myeloma].
    Juul JS, Larsen T, Marcussen N, Pedersen EB.
    Ugeskr Laeger; 2012 Apr 23; 174(17):1159-60. PubMed ID: 22533933
    [Abstract] [Full Text] [Related]

  • 35. Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment.
    Gertz MA.
    Am J Hematol; 2013 May 23; 88(5):416-25. PubMed ID: 23605846
    [Abstract] [Full Text] [Related]

  • 36. Coexistence of myeloma cast nephropathy, light chain deposition disease, and nonamyloid fibrils in a patient with multiple myeloma.
    Qian Q, Leung N, Theis JD, Dogan A, Sethi S.
    Am J Kidney Dis; 2010 Nov 23; 56(5):971-6. PubMed ID: 20870327
    [Abstract] [Full Text] [Related]

  • 37. Light chain deposition disease without glomerular proteinuria: a diagnostic challenge for the nephrologist.
    Sicard A, Karras A, Goujon JM, Sirac C, Bender S, Labatut D, Callard P, Sarkozy C, Essig M, Vanhille P, Provot F, Nony A, Nochy D, Ronco P, Bridoux F, Touchard G.
    Nephrol Dial Transplant; 2014 Oct 23; 29(10):1894-902. PubMed ID: 24619059
    [Abstract] [Full Text] [Related]

  • 38. The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis.
    Nasr SH, Said SM, Valeri AM, Sethi S, Fidler ME, Cornell LD, Gertz MA, Dispenzieri A, Buadi FK, Vrana JA, Theis JD, Dogan A, Leung N.
    Kidney Int; 2013 Mar 23; 83(3):463-70. PubMed ID: 23302715
    [Abstract] [Full Text] [Related]

  • 39. Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimens.
    Bochtler T, Hegenbart U, Kunz C, Granzow M, Benner A, Seckinger A, Kimmich C, Goldschmidt H, Ho AD, Hose D, Jauch A, Schönland SO.
    J Clin Oncol; 2015 Apr 20; 33(12):1371-8. PubMed ID: 25779559
    [Abstract] [Full Text] [Related]

  • 40. [Heart transplantation and the subsequent treatment of AL amyloidosis].
    Adam Z, Krejčí J, Krejčí M, Němec P, Spinarová L, Zampachová V, Cermáková Z, Pika T, Pour L, Kořístek Z, Tomíška M, Szturz P, Král Z, Mayer J.
    Vnitr Lek; 2013 Feb 20; 59(2):136-47. PubMed ID: 23461404
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 120.